Works matching IS 0008543X AND DT 2021 AND VI 127 AND IP 12


Results: 31
    1
    2

    Erratum.

    Published in:
    2021
    Publication type:
    corrected article
    3
    4
    5
    6

    Passing the baton.

    Published in:
    Cancer (0008543X), 2021, v. 127, n. 12, p. 1957, doi. 10.1002/cncr.33583
    By:
    • Khuri, Fadlo R.
    Publication type:
    Article
    8
    9

    Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice.

    Published in:
    2021
    By:
    • Clavio, Marino;
    • Crisà, Elena;
    • Miglino, Maurizio;
    • Guolo, Fabio;
    • Ceccarelli, Manuela;
    • Salvi, Flavia;
    • Allione, Bernardino;
    • Ferrero, Dario;
    • Balleari, Enrico;
    • Finelli, Carlo;
    • Poloni, Antonella;
    • Selleri, Carmine;
    • Danise, Paolo;
    • Cilloni, Daniela;
    • Di Tucci, Anna Angela;
    • Cametti, Gianni;
    • Freilone, Roberto;
    • Fanin, Renato;
    • Bigazzi, Catia;
    • Zambello, Renato
    Publication type:
    journal article
    10
    11
    12
    13
    14

    Long-term follow-up of salvage therapy using a combination of inotuzumab ozogamicin and mini-hyper-CVD with or without blinatumomab in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia.

    Published in:
    2021
    By:
    • Jabbour, Elias;
    • Sasaki, Koji;
    • Short, Nicholas J.;
    • Ravandi, Farhad;
    • Huang, Xuelin;
    • Khoury, Joseph D.;
    • Kanagal‐Shamanna, Rashmi;
    • Jorgensen, Jeffrey;
    • Khouri, Issa F.;
    • Kebriaei, Partow;
    • Jain, Nitin;
    • Alvarado, Yesid;
    • Kadia, Tapan M.;
    • Paul, Shilpa;
    • Garcia‐Manero, Guillermo;
    • Dabaja, Bouthaina S.;
    • Burger, Jan A.;
    • DiNardo, Courtney D.;
    • Daver, Naval A.;
    • Montalban‐Bravo, Guillermo
    Publication type:
    journal article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    27
    28
    29
    30

    A phase 3 trial of azacitidine versus a semi‐intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia.

    Published in:
    Cancer (0008543X), 2021, v. 127, n. 12, p. 2003, doi. 10.1002/cncr.33403
    By:
    • Vives, Susana;
    • Martínez‐Cuadrón, David;
    • Bergua Burgues, Juan;
    • Algarra, Lorenzo;
    • Tormo, Mar;
    • Martínez‐Sánchez, María Pilar;
    • Serrano, Josefina;
    • Herrera, Pilar;
    • Ramos, Fernando;
    • Salamero, Olga;
    • Lavilla, Esperanza;
    • López‐Lorenzo, José L.;
    • Gil, Cristina;
    • Vidriales, Belén;
    • Falantes, Jose F.;
    • Serrano, Alfons;
    • Labrador, Jorge;
    • Sayas, María J.;
    • Foncillas, María Á.;
    • Amador Barciela, María L.
    Publication type:
    Article
    31

    Issue Information.

    Published in:
    Cancer (0008543X), 2021, v. 127, n. 12, p. 1941, doi. 10.1002/cncr.32312
    Publication type:
    Article